Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated
Karin J Purdie1, Catherine A Harwood, Abha Gulati
1Cancer Research UK Skin Tumour Laboratory, ICMS, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, London, UK. k.purdie@qmul.ac.uk
The Journal of Investigative Dermatology
|January 10, 2009
Summary
Genomic analysis of cutaneous squamous cell carcinoma (cSCC) reveals frequent genetic aberrations, particularly loss of heterozygosity at 3p and 9p. Well-differentiated cSCCs show distinct genetic profiles, suggesting a unique tumor subpopulation.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Cutaneous squamous cell carcinoma (cSCC) is a common cancer in fair-skinned individuals.
- The genetic drivers of cSCC tumorigenesis are not fully understood due to tumor heterogeneity.
Purpose of the Study:
- To investigate genome-wide allelic imbalance in cSCC using SNP microarray analysis.
- To identify key molecular events and genetic aberrations in cSCC development.
- To explore the genetic differences between well-differentiated and poorly differentiated cSCCs.
Main Methods:
- Single nucleotide polymorphism (SNP) microarray analysis was performed on 60 cSCC samples and paired non-tumor tissues.
- Genome-wide allelic imbalance, including loss of heterozygosity (LOH) and microdeletions, was assessed.
- Statistical analysis was used to correlate genetic aberrations with tumor differentiation, immune status, and human papillomavirus (HPV) status.
Main Results:
- Loss of heterozygosity at 3p (65%) and 9p (75%) were the most frequent recurrent aberrations in cSCC.
- Microdeletions involving the PTPRD gene at 9p23 (15%) and FHIT gene at 3p14.2 (5%) were identified.
- Well-differentiated cSCCs exhibited significantly fewer genetic aberrations compared to moderately and poorly differentiated tumors.
- No correlation was found between chromosomal aberrations and immune or HPV status.
Conclusions:
- Frequent LOH at 3p and 9p are significant events in cSCC tumorigenesis.
- PTPRD and FHIT are potential tumor suppressor genes implicated in cSCC development.
- Well-differentiated cSCCs represent a genetically distinct subpopulation, warranting further investigation.
Related Concept Videos
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...